长药控股
(300391)
| 流通市值：13.38亿 | | | 总市值：13.38亿 |
| 流通股本：3.50亿 | | | 总股本：3.50亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,021,867,556.56 | 476,013,480.79 | 136,792,880.94 | 1,615,322,934.59 |
| 营业收入 | 1,021,867,556.56 | 476,013,480.79 | 136,792,880.94 | 1,615,322,934.59 |
| 二、营业总成本 | 1,009,385,751.03 | 473,816,549.47 | 161,381,485.12 | 1,488,403,209.16 |
| 营业成本 | 859,108,791.9 | 397,395,765.81 | 125,651,605.96 | 1,268,545,027.21 |
| 税金及附加 | 2,413,448.38 | 1,731,424.54 | 660,017.33 | 7,032,752.42 |
| 销售费用 | 24,818,129.53 | 9,806,918.31 | 4,741,782.77 | 33,242,357.96 |
| 管理费用 | 59,528,798.3 | 40,540,838.37 | 18,104,968.73 | 103,081,927.54 |
| 研发费用 | 6,136,499.43 | 3,664,268.3 | 2,011,134.43 | 25,758,873.45 |
| 财务费用 | 57,380,083.49 | 20,677,334.14 | 10,211,975.9 | 50,742,270.58 |
| 其中:利息费用 | 59,240,814.7 | 21,670,557.17 | 9,478,334.98 | 56,030,666.18 |
| 其中:利息收入 | 72,237.97 | 29,256.26 | 18,865.02 | 377,459.08 |
| 加:投资收益 | - | - | - | 55,186,332.95 |
| 资产处置收益 | -304,353.1 | -464,188.9 | - | 49,504.46 |
| 资产减值损失(新) | -106,889,069.86 | -78,867,667.24 | -203,686.75 | -51,611,029.9 |
| 信用减值损失(新) | -102,547,563.34 | -48,564,941.72 | -7,428,266.98 | -56,929,377.11 |
| 其他收益 | 1,753,592.61 | 1,479,757.72 | 348,018.94 | 6,330,665.5 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -195,505,588.16 | -124,220,108.82 | -31,872,538.97 | 79,945,821.33 |
| 加:营业外收入 | 81,282,206.95 | 81,094,937.11 | 23,351.16 | 9,888,633.17 |
| 减:营业外支出 | 1,179,454.13 | 334,945.15 | 76,607.38 | 18,008,758.15 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -115,402,835.34 | -43,460,116.86 | -31,925,795.19 | 71,825,696.35 |
| 减:所得税费用 | 22,188,424.27 | -5,855,574.79 | -1,112,574.47 | 27,253,562.62 |
| 六、净利润 | -137,591,259.61 | -37,604,542.07 | -30,813,220.72 | 44,572,133.73 |
| 持续经营净利润 | -204,376,348.93 | -15,342,845.63 | -30,813,220.72 | 44,572,133.73 |
| 归属于母公司股东的净利润 | -115,852,394.22 | -24,215,061.46 | -22,958,141.64 | -23,273,315.49 |
| 少数股东损益 | -21,738,865.39 | -13,389,480.61 | -7,855,079.08 | 67,845,449.22 |
| (一)基本每股收益 | -0.33 | -0.07 | -0.07 | -0.07 |
| (二)稀释每股收益 | -0.33 | -0.07 | -0.07 | -0.07 |
| 九、综合收益总额 | -137,591,259.61 | -37,604,542.07 | -30,813,220.72 | 44,572,133.73 |
| 归属于母公司股东的综合收益总额 | -115,852,394.22 | -24,215,061.46 | -22,958,141.64 | -23,273,315.49 |
| 归属于少数股东的综合收益总额 | -21,738,865.39 | -13,389,480.61 | -7,855,079.08 | 67,845,449.22 |
| 公告日期 | 2023-10-25 | 2023-08-23 | 2023-04-28 | 2023-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |